Prevalence of Hyperuricemia in Smoker Population with Type-2 Diabetes Mellitus

Abstract

Objective

To determine the prevalence of hyperuricemia in smoker population with type 2 diabetes mellitus.

Methodology

A descriptive cross-sectional study was undertaken in the Internal Medicine Department at Jinnah Postgraduate Medical Centre in Karachi, Pakistan, from June 2021 to December 2021. The study was conducted involving smoking populated individuals diagnosed with type 2 diabetes mellitus. The diagnosed cases who fulfilled the inclusion criteria were included in the study. The participants’ blood samples were taken to assess the uric acid to confirm hyperuricemia. The data was analyzed in SPSS version 26.0.

Results

In this study, a total of 576 diabetic patients diagnosed with type II were enrolled. The mean age was 51.31±13.76 an age range of 18 and 85 years. Males were dominant i.e. 66.7% v/s 33.3% females. Hyperuricemia was prevalent in 28.125% of patients.

Conclusion

It is to be concluded that hyperuricemia is prevalent in type II diabetic smoker patients. Since the study was conducted on a limited sample size from a single hospital, the findings may not accurately represent the situation across the entire country, and in order to generalise the results of our research, it must be assessed further in a broader sample of patients at other hospitals throughout the nation.